Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

8,823 evidence items · page 48 / 353

770,000 deathsHIV resulted in 770,000 deaths annually globally in 2018.

NigeriaVIH/sidaobserved 2018published 2021Journal of medical virologyPubMeddocument of 11 observations

2.6 %The prevalence of Gestational Diabetes Mellitus (GDM) in the study was 2.6% using the 1999 WHO diagnostic criteria.

Nigeriagestational diabetes mellitus (GDM)published 2020The Pan African medical journalPubMeddocument of 5 observations

49.5 %HSV-2 prevalence among sexual and gender minorities with HIV-1 in Lagos, Nigeria was 49.5%.

NigeriaHerpes simplex virus type 2 · VIH/sidapublished 2023AIDS research and human retrovirusesPubMeddocument of 3 observations

35.8 %The prevalence of optimal short-term glycemic control among Type 2 diabetic patients was 35.8%.

Nigeriadiabète de type 2published 2025African health sciencesPubMeddocument of 5 observations

65.8 %Of the 73 participants with diabetes mellitus, 65.8% were males.

Nigeriadiabète (non précisé)observed March-May 2021published 2022International journal of environmental research and public healthPubMeddocument of 12 observations

76 %The prevalence of neurologic conditions among stable COPD patients in a Nigerian hospital's chest clinic was 76.0%.

NigeriaCOPD · neurologic conditionspublished 2025West African journal of medicinePubMeddocument of 20 observations

11.1 %The prevalence of anaemia was 11.1% among patients infected with malaria alone.

Nigeriaanémie · paludismepublished 2013African health scienceseurope_pmcdocument of 5 observations

1 MOIThe multiplicity of infection (MOI) per household ranged from 1.0 to 4.5.

Nigeriapaludismepublished 2020Malaria journalPubMeddocument of 7 observations

76.7 %76.7% of respondents were Christians in a study of breast cancer patients at University College Hospital, Ibadan, Nigeria.

Nigeriacancer du seinobserved 2018published 2019Journal of global oncologyPubMeddocument of 9 observations

38.7 %Low grade squamous intraepithelial lesion (LGSIL) had the highest frequency at 38.7% among pre-malignant lesions.

Nigerialow grade squamous intraepithelial lesion (LGSIL)observed 2017published 2022The Pan African medical journalPubMeddocument of 7 observations

48 %The seroprevalence of chikungunya and malaria was 48.0% in the southern region of Nigeria.

Nigeriachikungunyapublished 2022International journal of environmental research and public healthPubMeddocument of 6 observations

3,979 casesThe incidence patterns model predicted 3979 new HIV infections among the 15 to 49 subpopulations in Lagos state.

NigeriaVIH/sidapublished 2024Journal of the International Association of Providers of AIDS CarePubMeddocument of 7 observations

Malaria incidence was higher in the months with the highest rainfall recorded (June–August) in Abuja, Nigeria, between 2000 and 2013.

Nigeriapaludismeobserved 2000 to 2013published 2020International journal of environmental research and public healthPubMeddocument of 5 observations

25 %In 2022, test positivity rate (TPR) at Secondary Health Facilities (SHFs) decreased from 25% to 18%.

Nigeriapaludismeobserved 2022published 2025Malaria journalPubMeddocument of 9 observations

19.2 weeksMean time to death during treatment among DR-TB patients is 19.2 weeks.

NigeriaDrug-Resistant tuberculosis (DR-TB)published 2019PloS onePubMeddocument of 10 observations

0.035 p-valueAssociation analysis between paired single alleles at pfcrt and pfmdr1 loci showed a significant association (p=0.0349).

Nigeriapaludismepublished 2006Parasitology researcheurope_pmcdocument of 12 observations

11 %Only 11% of the treatment cards had patient adherence to isoniazid assessed.

NigeriaVIH/sidapublished 2022Malawi medical journal : the journal of Medical Association of MalawiPubMeddocument of 4 observations

23.7 %Malaria prevalence was 23.7% among women who had a 2-month interval between each sulfadoxine-pyrimethamine dose.

Nigeriapaludismepublished 2022African health sciencesPubMeddocument of 22 observations

41,804 casesNigeria had 41,804 confirmed SARS-CoV-2 cases as of 29 July 2020.

NigeriaCOVID-19observed 29 July 2020HAL · Unilimdocument of 97 observations

25 %Breast cancer constitutes 25% of all cancer cases diagnosed in Kano State, Nigeria.

Nigeriacancer du seinpublished 2025Breast cancer (Tokyo, Japan)PubMeddocument of 8 observations

44 %Breast cancer has a 5-year survival of 44% in Nigeria.

Nigeriacancer du seinpublished 2026JCO global oncologyPubMeddocument of 3 observations

0 p-valueA positive correlation was observed between RDW and MCHC (p-value = 0.0002) in patients with type II diabetes mellitus.

Nigeriadiabète (non précisé)published 2023West African journal of medicinePubMeddocument of 8 observations

0.6 proportionOver 6 in 10 women and girls living with HIV had limited access to HIV services during the COVID-19 pandemic in Nigeria.

NigeriaVIH/sidaobserved 2021published 2022African journal of AIDS research : AJARPubMeddocument of 4 observations

32.9 %In a study of 146 HIV-infected children in Calabar, Nigeria, conducted from February 1 to September 30, 2015, the prevalence of microalbuminuria was 32.9%.

Nigeriamicroalbuminuria · VIH/sidaobserved February 1 to September 30, 2015published 2022Saudi journal of kidney diseases and transplantation : an official publication of the SaudPubMeddocument of 5 observations

Of 51 consecutive children with cerebral malaria, fever, convulsions, and drowsiness were the commonest presenting symptoms.

Nigeriapaludismepublished 1997African journal of medicine and medical scienceseurope_pmcdocument of 7 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.